Sign In
Buy KVUE
$19.24
-0.0700 (-0.363%)
At Close: Jul 31, 2026
J&J Kenvue spinoff adds slew of banks to its initial public offering roster
02:32pm, Monday, 06'th Mar 2023
Kenvue Inc., the consumer products spinoff from Johnson & Johnson JNJ, +0.89% , has grown the roster of banks underwriting its initial public offering beyond the two original leads . Goldman Sachs & C
Blue-Chip Stocks And Red Flags - Things To Consider In Your Due Diligence
11:35am, Wednesday, 18'th Jan 2023
Investing in blue-chip companies that pay dividends and relentlessly focusing on reinvesting the proceeds is a proven strategy for reliable long-term returns. But what about the occasional black swan?
J&J's Spin-Off Kenvue Lists for IPO in Healthcare Giant Split
10:35pm, Monday, 09'th Jan 2023
As markets open for the new year, a mega breakup that could shake up the consumer healthcare market is coming down the initial public offering (IPO) pipeline.
Kenvue Begins IPO Process As It Seeks To Separate From Johnson & Johnson
12:19am, Saturday, 07'th Jan 2023
Kenvue has filed to go public as part of its separation process from parent firm Johnson & Johnson. The company sells consumer healthcare and wellness products worldwide.
